17
Views
23
CrossRef citations to date
0
Altmetric
Original Article

GPCR Drug Discovery Through the Exploitation of Allosteric Drug Binding Sites

, &
Pages 261-268 | Published online: 04 Dec 2011

References

  • Abdalla, S., Lother, H., and Quitterer, U. 2001. Nature 407:94–98.
  • Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., and Berger, E. A. 1996. Science 272:1955–1958.
  • Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., Meguro, K., and Fujino, M. 1999. Proc. Natl. Acad. Sci. USA 96:5698–5703.
  • Bahia, D. S., Wise, A., Fanelli, F., Lee, M., Rees, S., and Milligan, G. 1998. Biochemistry 37:11555–11562.
  • Bieniassz, P. D., Fridell, R. A., Aramori, I., Ferguson, S. S., Caron, M. G., and Cullen, B. R. 1997. EMBO J. 16:2599–2609.
  • Boss, V., Talpade, D. J., and Murphy, T. J. 1996. J. Biol. Chem. 271:10429–10432.
  • Carreras,C.W., Siani, M.A., Santi,D. V., and Dillon, S. B. 2002. Anal. Biochem. 300:146–151.
  • Chen, G., Way, J., Armour, S., Watson, C., Queen, K., Jayawickreme, C. K., Chen, W. J., and Kenakin, T. 2000. Mol. Pharmacol. 57:125–134.
  • Chen, W., Shields, T. S., Stork, P. J. S., and Cone, R. D. 1995. Anal. Biochem. 226:349–354.
  • Clare, J. J., Tate, S. N., Nobbs, M., and Romanos, M. A. 2000. Drug Discovery Today 5:506–520.
  • Deng, H., Unutmaz, D., Kewalramani, V. N., and Littman, D. R. 1997. Nature 388:296–300.
  • Denyer, J., Worley, J., Cox, B., Allenby, G., and Banks,M.1998. Drug Discovery Today 3:323–332.
  • Doms, R. W., and Peiper, S. C. 1997. Virol. 235:179–190.
  • Doranz, B. J., Lu, Z.-H., Rucker, J., Zhang, T.-Y., Sharron, M., Cen, Y.-H., Wang, Z.-X., Guo, H.-H., Du, J.-D., Accavitti, M. A., Doms, R. W., and Peiper, S. C. 1997. J. Virol. 71:6305–6314.
  • Doranz, B. J., Rucker, J., Smyth, Y., Samson, R. J., Peiper, S. C., Parmentier, M., Collman, R. G., and Doms, R. W. 1996. Cell 85:1149–1158.
  • Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., and Paxton, W. A. 1996. Nature 381:667–673.
  • Drews, J. 2000. Science 287:1960–1964.
  • Evans, N. A., Groarke, D. A., Warrack, J., Greenwood, C. J., Dodgson, K., Milligan, G., and Wilson, S. 2001. J. Neurochem. 22:476–485.
  • Fernandes, P. B. 1998. Curr. Opin. Chem. Biol. 2:597–603.
  • Finke, P. E., Oates, B., Mills, S. G., MacCoss, M., Malkowitz, L., Springer, M. S., Gould, S. L., DeMartino, J. A., Carella, A., Carver, G., Holmes, K., Danzeisen, R., Hazuda, D., Kessler, J., Lineberger, J., Miller, M., Schleif, W. A., and Emini, E. A. 2001. Bioorg. Med. Chem. Lett. 11:2475–2479.
  • Fitzgerald, L. R., Mannan, I. J., Dytko, G. M., Wu, H.-L., and Nambi, P. 1999. Anal. Biochem. 275:54–61.
  • Fong, C. W., Bahia, D. S., Rees, S., and Milligan, G. 1998. Mol. Pharmacol. 54:249–257.
  • Gao, Z.-G., Van Muiijlwijk-Koezen, J. E., Chen, A., Muller, C. E., Ijzerman, A. P., and Jacobson, K. A. 2001. Mol. Pharmacol. 60:1057–1063.
  • Goldin, S. M. 1997. D&MD Report No. 909 (Vol. 4) IBC.
  • Gutkind, J. S. 1998. J. Biol. Chem. 273:1839–1842.
  • Hedlund, P. B., Carson, M. J., Sutcliffe, J. G., and Thomas, E. A. 1999. Biochem. Pharmacol. 58:1807–1813.
  • Hejnova, L., Tucek, S., and El Fakahany, E. E. 1995. Eur. J. Pharmacol. 291: 427 – 430. Hill, S. J., Baker, J. G., and Rees, S. 2001. Curr. Opin. Pharmacol. 1:526–532.
  • Hoare, S. R., and Strange, P. G. 1996. Mol. Pharmacol. 50:1295–1308.
  • Ijzerman, A., Kourounakis, A., and van der Klein, P. 2001. Farmaco. 56:67–70.
  • Jaubic, J., Bacakova, L., Lisa, V., El-Fakahany, E. E., and Tucek, S. 1996. Proc. Natl. Acad. Sci USA 93:8705–8709.
  • Jayawickreme, C., Sauls, H., Bolio, N., Ruan, J., Moyer, M., Burkhart, W., Marron, B., Rimele, T., and Shaffer, J. 1999. J. Pharmacol. Toxicol. Methods. 42:189–197.
  • Jones, R. E., Defeo-Jones, D., McAvoy, E. M., Vuocolo, G. A., Wegrzyn, R. J., Haskell, K. M., and Oliff, A. 1991. Oncogene 6:745–751.
  • Kariv, I., Stevens, M. E., and Behrens, D. L. 1999. J. Biomol. Screen 4:27–32.
  • Kolias-Baker, C., Ruble, J., Dennis, D., Bruns, R. F., Linden, J., and
  • Belardinelli, L. 1994. Circ. Res. 7:961–971.
  • Konig, M., Mahan, L. C., Marsh, J. W., Fink, J. S., and Brownstein, M. J. 1991. Mol. Cell Neurosci. 2:331–337.
  • Kourounakis, A., Visser, C., de Groote, M., and Ijzerman, A. P. 2001. Biochem. Pharmacol. 61:137–144.
  • Kristen, L. P., Luttrell, L. M., and Lefkowitz, R. J. 2001. Oncogene. 20:1532–1539.
  • Lazareno, S., and Birdsall, N. J. 1995. Mol. Pharmacol. 48:362–378.
  • Lee, B., Sharron, M., Blanpain, C., Doranz, B. J., Vakili, J., Setoh, P., Berg, E., Liu, G., Guy, H. R., Durell, S. R., Parmentier, M., Chang, C. N., Price, K., Tsang, M., and Doms, R. W. 1999. J. Biol. Chem. 274:9617–9626.
  • Leppik, R. A., and Birdsall, N. J. 2000. Mol. Pharmacol. 58:1091–1099.
  • Litschig, S., Gasparini, Rueegg, D. F.Stoehr, N., Flor, P. J., Vranesic, I., Prezeau, L., Pin, J. P. Thomsen, C, and Kuhn, R. 1999. Mol. Pharmacol. 55:453–461.
  • Maeda, K., Yoshimura, K., Shibayama, S., Habashita, H., Tada, H., Sagawa, K., Miyakawa, T., Aoki, M., Fukushima, D., and Mitsuya, H. 2000. J. Biol. Chem. 276:35195–35200.
  • Milligan, G., and Rees, S. 1999. Trends Pharmacol. Sci. 20:118–124.
  • Mount, R. C, Jordan, B. E., and Hatfield, C. 1996. Meth. Mol. Biol. 53:239–248.
  • North, R. A., ed. 1995. Ligand and voltage gated ion channels. CRC Press: Boca Raton, Florida.
  • Offermanns, S., and Simon, M. I. 1995. J. Biol. Chem. 270:15175–15180.
  • Prystay, L., Gagne, A., Kasila, P., Yeh, L., and Banks, P. 2001. J. Biomol. Screening 6:75–82.
  • Rao, A., Luo, C, and Hogan, P. G. 1997. Ann. Rev. Immunol. 15:707–747.
  • Rees, S., Brown, S., and Stables, J. 1999. Reporter gene systems for the study of G-protein coupled receptor signal transduction in mammalian cells. In Signal transduction: A practical approach, 2d ed. Edited by G. Milligan, Oxford University Press: Oxford, UK.
  • Rees, S., Martin, D. P., Scott, S. V., Brown, S. H., Fraser, N., O'Shaughnessey, C, and Beresford, I. 2001. J. Biomol. Screening 6:19–27.
  • Scheirer, W. 1997. Reporter gene assay applications. In High throughput screening: The discovery ofbioactive substances, ed. J. P. Devlin, New York: Marcel Dekker Inc., pp. 43–52.
  • Schroeder, K. S., and Neagle, B. D. 1996. J. Biomol. Screening 2:75–80.
  • Shaywitz, A. J., and Greenberg, M. E. 1999. Ann. Rev. Biochem. 68:821–861.
  • Spooren, W. P. J. M., Gasparini, F, Salt, T. E., and Kuhn, R. 2001. Trends Pharmacol. Sci. 22:331–337.
  • Staudinger, R., Wang, X., and Bandres, J. C. 2001. Biochem. Biophys. Res. Comm. 286:41–47.
  • Urwyler, S., Mosbacher, J., Lingenhoehl, K., Heid, J., Hofetetter, K., Froestl, W., Bettler, B., and Kaupmann, K. 2001. Mol. Pharmacol. 60:963–971.
  • Waugh, D. J., Gaivin, R. J., Damron, D. S., Ray, P. A., and Perez, D. M. 1999. J. Pharmacol. Exp. Ther. 291:1164–1171.
  • Wise, A., Gearing, K., and Rees, S. 2002. Drug Discovery Today 7:235–246.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.